Fetal hypoxia is associated with elevated cord serum C-reactive protein levels in diabetic pregnancies

Biology of the Neonate

Volumn 85, Issue 4, 2004, Pages 237-242

  Loukovaara, Mikko ^a   Leinonen, Pekka ^a   Teramo, Kari ^a   Alfthan, Henrik ^a   Stenman, Ulf Håkan ^a   Andersson, Sture ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

C reactive protein; Erythropoietin; Gestational diabetes; Hypoxia; Type 1 diabetes; Umbilical artery gas variables

Indexed keywords

C REACTIVE PROTEIN; ERYTHROPOIETIN;

ADULT; AMNION FLUID; ARTICLE; CARBON DIOXIDE TENSION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FETUS; FETUS HYPOXIA; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; OXYGEN TENSION; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UMBILICAL ARTERY; UMBILICAL CORD BLOOD;

ADULT; AMNIOTIC FLUID; BODY MASS INDEX; C-REACTIVE PROTEIN; CARBON DIOXIDE; DIABETES MELLITUS, TYPE 1; ERYTHROPOIETIN; FEMALE; FETAL BLOOD; FETAL HYPOXIA; FLUOROIMMUNOASSAY; HUMANS; HYDROGEN-ION CONCENTRATION; INFLAMMATION; OXYGEN; PREGNANCY; PREGNANCY IN DIABETICS; REGRESSION ANALYSIS; UMBILICAL ARTERIES;

EID: 3042523853     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076132     Document Type: Article

References (22)

1. Pepys MB, Berger A: The renaissance of C reactive protein: It may be a marker not only of acute illness but also of future cardiovascular disease. BMJ 2001;322:4-5.
2. Du Clos TW: Function of C-reactive protein. Ann Med 2000;32:274-278.
3. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM: C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-334.
4. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ, Sattar N: C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 2002;51:1596-1600.
5. Gibney J, Weis U, Turner B, Meeking DR, Cansfield J, Watts GF, Shaw KM, Cummings MH: Postischemic microcirculatory blood flow correlates negatively and independently with plasma C-reactive protein in long-standing type 1 diabetes. Diabetes Care 2002;25:802-803.
6. Targher G, Zenari L, Bertolini L, Muggeo M, Zoppini G: Elevated levels of interleukin-6 in young adults with type 1 diabetes without clinical evidence of microvascular and macrovascular complications. Diabetes Care 2001;24:956-957.
7. Pickup JC, Chusney GD, Thomas SM, Burt D: Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci 2000;67:291-300.
8. Nelson KB, Willoughby RE: Infection, inflammation and the risk of cerebral palsy. Curr Opin Neurol 2000;13:133-139.
9. Yoon BH, Romero R, Park JS, Kim CJ, Kim SH, Choi JH, Han TR: Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000;182:675-681.
10. Schwartz R, Teramo KA: Effect of diabetic pregnancy on the fetus and newborn. Semin Perinatol 2000;24:120-135.
11. Pettitt DJ, Aleck KA, Baird HR, Carraher MJ, Bennett PH, Knowler WC: Congenital susceptibility to NIDDM: Role of intrauterine environment. Diabetes 1988;37:622-628.
12. Silverman BL, Metzger BE, Cho NH, Loeb CA: Impaired glucose tolerance in adolescent offspring of diabetic mothers: Relationship to fetal hyperinsulinism. Diabetes Care 1995;18:611-617.
13. Sobngwi E, Boudou P, Mauvais-Jarvis F, Leblanc H, Velho G, Vexiau P, Porcher R, Hadjadj S, Pratley R, Tataranni PA, Calvo F, Gautier JF: Effect of a diabetic environment in utero on predisposition to type 2 diabetes. Lancet 2003;361:1861-1865.
14. Hyvönen K: Gestaatiodiabeteksen esiintyvyys ja seulonta (Incidence and screening of gestational diabetes). Publications of the University of Kuopio, Finland. Original reports 6/1991.
15. Teramo KA, Widness JA, Clemons GK, Voutilainen PE, McKinlay S, Schwartz R: Amniotic fluid erythropoietin correlates with umbilical plasma erythropoietin in normal and abnormal pregnancy. Obstet Gynecol 1987;69:710-716.
16. Pihkala J, Hakala T, Voutilainen P, Raivio K: Uudet suomalaiset sikiön kasvukäyrät (Characteristic of recent fetal growth curves in Finland). Duodecim 1989;105:1540-1546.
17. Hemmilä I, Dakubu S, Mukkala VM, Siitari H, Lövgren T: Europium as a label in time-resolved immunofluorometric assays. Anal Biochem 1984;137:335-343.
18. Alfthan H, Schroder J, Fraser R, Koskimies A, Halila H, Stenman UH: Choriogonadotropin and its beta subunit separated by hydrophobic-interaction chromatography and quantified in serum during pregnancy by time-resolved immunofluorometric assays. Clin Chem 1988;34:1758-1762.
19. Husari M, Markkanen H, Puttonen H, Teramo K: Lapsiveden erytropoietiinipitoisuus normaaleissa ja patologisissa raskauksissa (Amniotic fluid erythropoietin levels in normal and pathological pregnancies). Duodecim 1998;114:2315-2321.
20. Adamson JW: Regulation of red blood cell production. Am J Med 1996;101(suppl 2A):4S-6S.
21. Ford ES: Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 1999;22:1971-1977.
22. Kilpatrick ES, Keevil BG, Jagger C, Spooner RJ, Small M: Determinants of raised C-reactive protein concentration in type 1 diabetes. QJM 2000;93:231-236.